Jun 01, 2021 / 04:20PM GMT
Brian Weinstein - William Blair & Company - Analyst
Good afternoon or good morning depending where you are. My name is Brian Weinstein, and I am the group head of life sciences here at William Blair & Company, and I am responsible for coverage of Veracyte. Before we get into the discussion, I am required to inform you that for a complete list of disclosures, please go to our website at williamblair.com.
Logistically, the format here is a fireside chat between me and the management, and that should last for about 30 minutes. We have a set of questions prepared, which we will get through, but if you have a question, you can submit it by typing it into the question box that is provided. We will try and keep an eye out for it but really can't guarantee that we will be able to get to everything in the time allotted.
With that, let's jump in. We're fortunate to have in what I am going to assume might be her final formal investor presentation -- I don't know how it is going to work out -- Bonnie Anderson, who effective yesterday, moved to the Executive Chairman role after being CEO at
Veracyte Inc at William Blair Growth Stock Conference (Virtual) Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers